The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Open accessAbstract
The permeability of insulin (Ins), nerve growth factor (NGF), albumin (Alb), transferrin (Trf), and IgG across the blood-nerve barrier (BNB) and blood-brain barrier (BBB) in normal adult rats was quantified by measuring the (permeability coefficient x surface area) product (PS) with the i.v. bolus-injection technique in the cannulated brachial vein and artery using radioiodinated proteins. The PS values of the BNB for IgG and Alb were low: 0.079 +/- 0.029 x 10(-6) and 0.101 +/- 0.088 x 10(-6) ml.g-1.s-1, (mean +/- SD, respectively). The PS values for NGF and Trf were 16.1-fold and 25.5-fold higher than for Alb. The PS for Ins across the BNB was 33.190 +/- 2.053 x 10(-6) ml.g-1.s-1--a remarkable 329-fold increase compared with Alb. The PS values of the BBB for IgG and Alb in different brain regions were all low, from 0.028 +/- 0.017 to 0.151 +/- 0.035 x 10(-6) ml.g-1.s-1 (mean +/- SD). NGF and Trf had comparable PS values from 13- to 32-fold higher than for Alb, except for the brain stem, where the PS for Trf was 66-fold higher than for Alb. The mean PS for Ins across the BBB ranged from 15.78 +/- 5.45 x 10(-6) ml.g-1.s-1 for the cortex to 22.62 +/- 7.50 x 10(-6) ml.g-1.s-1 for the brain stem--again a remarkable 105- to 390-fold increase relative to Alb. Because reliable PS measurements were obtained for all proteins tested, the BBB and BNB cannot be considered impermeable to proteins--a concept that has plagued brain- and nerve-barrier research. The low PS values for IgG and Alb indicate low rates of transfer; however, Alb, in particular, is the major protein of endoneurial and ventricular fluid, which suggests that these PS values may be significant. Ins had the highest PS values, which likely reflect the mechanism of transport across the barriers--that is, receptor-mediated transport. Because NGF and Trf had PS values 13- to 66-fold higher than for Alb, whether this reflects receptor-mediated uptake, adsorptive-mediated transcytosis, or some other mechanism is unclear. That the PS values for NGF and Trf differ from Alb and IgG clearly suggests, however, a different uptake mechanism. Finally, the remarkably high PS values for Ins across the BBB and BNB identify this protein and its putative receptor on capillary endothelial cells as a potential target for drug delivery into the central and peripheral nervous systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mAbs exhibit limited distribution to the brain, and mAb concentrations was determined to be 0.1–0.2 % and 0.02 % of the steady‐state circulating mAb concentration in rodents and cynomolgus monkey, respectively.92, 93”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
In the citing paper
“the PK of the anti‐Her2/CD3T cell‐dependent bispecific (TDB) antibody in rats demonstrated similar clearance and half‐life as trastuzumab.92”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808
An immunohistochemical study of the nerve growth factor receptor in developing rats
Yan, Q., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03481.1988 · Cited by 605
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 550
Taniuchi, M., Clark, H., Schweitzer, J. B., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-02-00664.1988 · Cited by 542
Receptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 474
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 454
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 410
Cited by
Sorted by citations
Items 101–200 of 378
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment
Xu, Y., Zhou, H., & Zhu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00106 · Cited by 67
Jin, X., Liu, J., Yang, Y. R., Liu, K. J., Yang, Y., & Liu, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.007 · Cited by 65
Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers
Poduslo, J. F., & Curran, G. L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90222-4 · Cited by 66
Self-citationZhou, A. L., Swaminathan, S. K., Curran, G. L., Poduslo, J. F., Lowe, V. J., Li, L., & Kandimalla, K. K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254201 · Cited by 64
Self-citationReinholz, M. M., Merkle, C. M., & Poduslo, J. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7142 · Cited by 62
Self-citationRedox-regulating role of insulin: The essence of insulin effect
Wang, X., Tao, L., & Hai, C. X. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.019 · Cited by 60
Kandimalla, K. K., Curran, G. L., Holasek, S. S., Gilles, E. J., Wengenack, T. M., & Poduslo, J. F. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081901 · Cited by 59
Self-citationKumar, N. N., Pizzo, M. E., Nehra, G., Wilken-Resman, B., Boroumand, S., & Thorne, R. G. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00548 · Cited by 60
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Alzghool, O. M., van Dongen, G. A. M. S., van de Giessen, E., Schoonmade, L. J., & Beaino, W. (2022) · Movement Disorders · doi:10.1002/mds.28984 · Cited by 64
Ruano-Salguero, J. S., & Lee, K. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-60438-z · Cited by 63
Transport of insulin and albumin by the microvascular endothelium of the rete mirabile
Bendayan, M., & Rasio, E. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.7.1857 · Cited by 59
Mahoney, M. J., & Saltzman, W. M. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601602 · Cited by 59
Sissung, T. M., Troutman, S. M., Campbell, T. J., Pressler, H. M., Sung, H., Bates, S. E., & Figg, W. D. (2012) · PubMed · Cited by 58
First egg protein with a neurotoxic effect on mice
Heras, H., Frassa, M. V., Fernández, P. E., Galosi, C. M., Gimeno, E. J., & Dreon, M. S. (2008) · Toxicon · doi:10.1016/j.toxicon.2008.06.022 · Cited by 57
Growth-Factor Delivery in Tissue Engineering
Saltzman, W. M. (1996) · MRS Bulletin · doi:10.1557/s0883769400031870 · Cited by 58
Pain, C., Dumont, J., & Dumoulin, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.01.012 · Cited by 60
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
Mantile, F., & Prisco, A. (2020) · Biology · doi:10.3390/biology9120425 · Cited by 56
Poduslo, J. F., Curran, G. L., Haggard, J. J., Biere, A. L., & Selkoe, D. J. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0132 · Cited by 52
Self-citationNanotechnology in regenerative ophthalmology
Sahle, F. F., Kim, S., Niloy, K. K., Tahia, F., Fili, C. V., Cooper, E., Hamilton, D. J., & Lowe, T. L. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.10.006 · Cited by 55
Picker, L. D., Victoriano, G. M., Richards, R., Gorvett, A. J., Lyons, S., Buckland, G. R., Tofani, T., Norman, J. L., Chatelet, D. S., Nicoll, J. A. R., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.017 · Cited by 58
Kashiwamura, Y., Sano, Y., Abe, M., Shimizu, F., Haruki, H., Maeda, T., Kawai, M., & Kanda, T. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0413-6 · Cited by 54
Trejo, J. L., Carro, E., Núñez, Á., & Torres‐Alemán, I. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.4.365 · Cited by 53
Murakami, K. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.940275 · Cited by 53
Drug Permeability: From the Blood–Brain Barrier to the Peripheral Nerve Barriers
Sun, Y., Zabihi, M., Li, Q., Li, X., Kim, B. J., Ubogu, E. E., Raja, S. N., Wesselmann, U., & Zhao, C. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200150 · Cited by 59
Syvänen, S., Fang, X. T., Hultqvist, G., Meier, S. R., Lannfelt, L., & Sehlin, D. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.01.004 · Cited by 53
Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration
Carrascosa, C., Torres‐Alemán, I., López-López, C., Carro, E., Espejo, L. A., Torrado, S., & Torrado, J. J. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00562-3 · Cited by 53
Localized Delivery of Proteins in the Brain: Can Transport Be Customized?
Haller, M. F., & Saltzman, W. M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011911912174 · Cited by 55
The Human Blood-Nerve Barrier Transcriptome
Palladino, S. P., Helton, E. S., Jain, P., Dong, C., Crowley, M. R., Crossman, D. K., & Ubogu, E. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-17475-y · Cited by 52
Yosef, N., Xia, R. H., & Ubogu, E. E. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c84a9a · Cited by 54
Teeling, J. L., Carare, R. O., Glennie, M. J., & Perry, V. H. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0995-3 · Cited by 51
Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
Maphis, N. M., Peabody, J., Crossey, E., Jiang, S., Ahmad, F. A. J., Álvarez, M. J., Mansoor, S. K., Yaney, A., Yang, Y., Sillerud, L. O., et al. (2019) · npj Vaccines · doi:10.1038/s41541-019-0118-4 · Cited by 48
Rodrigues, B. D. S., Kanekiyo, T., & Singh, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00218 · Cited by 51
Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
Wang, S., Yao, H., Xu, Y., Hao, R., Zhang, W., Liu, H., Huang, Y., Guo, W., & Lu, B. (2020) · Theranostics · doi:10.7150/thno.44165 · Cited by 52
Kiernan, J. A. (1996) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19961001)35:2 · Cited by 51
Pluhar, G. E., Grogan, P. T., Seiler, C., Goulart, M. R., SantaCruz, K. S., Carlson, C. S., Chen, W., Olin, M., Lowenstein, P. R., Castro, M. G., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.082 · Cited by 50
Anti-GM1 antibody facilitates leakage in an in vitro blood–nerve barrier model
Kanda, T., Iwasaki, T., Yamawaki, M., Tai, T., & Mizusawa, H. (2000) · Neurology · doi:10.1212/wnl.55.4.585 · Cited by 49
Deltorphin transport across the blood–brain barrier
Fiori, A., Cardelli, P., Negri, L., Savi, M. R., Ström, R., & Erspamer, V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9469 · Cited by 49
Ramakrishnan, M., Wengenack, T. M., Kandimalla, K. K., Curran, G. L., Gilles, E. J., Ramı́rez-Alvarado, M., Lin, J., Garwood, M., Jack, C. R., & Poduslo, J. F. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9600-9 · Cited by 49
Self-citationRadiolabelling small and biomolecules for tracking and monitoring
Edelmann, M. R. (2022) · RSC Advances · doi:10.1039/d2ra06236d · Cited by 48
Sano, Y., Shimizu, F., Nakayama, H., Abe, M., Maeda, T., Ohtsuki, S., Terasaki, T., Obinata, M., Ueda, M., Takahashi, R.-I., et al. (2007) · Cell Structure and Function · doi:10.1247/csf.07015 · Cited by 46
Wengenack, T. M., Curran, G. L., & Poduslo, J. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00041-3 · Cited by 45
Self-citationBlood–Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model
Takeshita, Y., Sato, R., & Kanda, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010062 · Cited by 50
Gustafsson, S. S., Gustavsson, T., Roshanbin, S., Hultqvist, G., Hammarlund‐Udenaes, M., Sehlin, D., & Syvänen, S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.001 · Cited by 44
Poletaev, A. B., Morozov, S., Gnedenko, B. B., Zlunikin, V. M., & Korzhenevskey, D. A. (2000) · Autoimmunity · doi:10.3109/08916930008995985 · Cited by 44
Abe, M., Sano, Y., Maeda, T., Shimizu, F., Kashiwamura, Y., Haruki, H., Saito, K., Tasaki, A., Kawai, M., Terasaki, T., et al. (2012) · Cell Structure and Function · doi:10.1247/csf.11042 · Cited by 42
Drug Distribution into Peripheral Nerve
Liu, H., Chen, Y., Huang, L. J., Sun, X., Fu, T., Wu, S., Zhu, X., Wei, Z. C., Liu, J., Lü, G., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245613 · Cited by 41
Madrasi, K. J., Das, R., Abdul, H. M., Lin, L., Hyman, B. T., Lauffenburger, D. A., Albers, M. W., Rissman, R. A., Burke, J. M., Apgar, J. F., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12312 · Cited by 40
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
Ojaimi, Y. A., Blin, T., Lamamy, J., Gracia, M., Pitiot, A., Denevault‐Sabourin, C., Joubert, N., Pouget, J., Gouilleux‐Gruart, V., Heuzé‐Vourc'h, N., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108022 · Cited by 44
- Self-citation
Rubio‐Beltrán, E., Labastida‐Ramírez, A., Haanes, K. A., van den Bogaerdt, A., Bogers, A. J. J. C., Dirven, C. M. F., Danser, A. J., Xu, C., Snellman, J., & MaassenVanDenBrink, A. (2019) · Cephalalgia · doi:10.1177/0333102419863027 · Cited by 39
An Immortalized Human Blood-Nerve Barrier Endothelial Cell Line for In Vitro Permeability Studies
Yosef, N., & Ubogu, E. E. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9882-7 · Cited by 39
Aging of blood-brain barrier and neuronal cells of eye and ear in SAM mice
Hosokawa, M., & Ueno, M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00029-9 · Cited by 39
Antibody delivery through the blood-brain barrier
Bickel, U. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00005-r · Cited by 38
Hadden, R. D. M., Gregson, N. A., Gold, R., Smith, K. J., & Hughes, R. A. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00421.x · Cited by 39
MR Microimaging of amyloid plaques in Alzheimer’s disease transgenic mice
Wengenack, T. M., Jack, C. R., Garwood, M., & Poduslo, J. F. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0706-9 · Cited by 38
Self-citationYosef, N., & Ubogu, E. E. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24100 · Cited by 38
Considerations for dosing immunoglobulin in obese patients
Hodkinson, J. P. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12955 · Cited by 38
Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities
Mané-Damas, M., Hoffmann, C., Zong, S., Tan, A., Molenaar, P. C., Losen, M. H., & Martínez‐Martínez, P. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102348 · Cited by 38
Thomas, S. A., Abbruscato, T. J., Hruby, V. J., & Davis, T. P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36531-0 · Cited by 38
Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel
Olthof, M. G. L., Kempen, D. H. R., Liu, X., Dadsetan, M., Tryfonidou, M. A., Yaszemski, M. J., Dhert, W. J. A., & Lu, L. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2664 · Cited by 37
Glycosphingolipid antibodies and blood–nerve barrier in autoimmune demyelinative neuropathy
Kanda, T., Yamawaki, M., Iwasaki, T., & Mizusawa, H. (2000) · Neurology · doi:10.1212/wnl.54.7.1459 · Cited by 37
Reduced maternal and cord nerve growth factor levels in preterm deliveries
Dhobale, M. V., Mehendale, S. S., Pisal, H., Nimbargi, V., & Joshi, S. (2012) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.12.007 · Cited by 36
Cationization increases brain distribution of an amyloid-beta protofibril selective F(ab’)2 fragment
Syvänen, S., Edén, D., & Sehlin, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.065 · Cited by 36
Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier
Sjöström, E. O., Culot, M., Leickt, L., Åstrand, M., Nordling, E., Gosselet, F., & Kaiser, C. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100307 · Cited by 37
Mattson, M. P., Goodman, Y., Luo, H., Fu, W., & Furukawa, K. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6 · Cited by 561
Elmorsy, E. M., Al-Ghafari, A. B., Almutairi, F. M., Aggour, A. M., & Carter, W. G. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.07.011 · Cited by 36
Bittner, G. D., Bushman, J. S., Ghergherehchi, C. L., Roballo, K. C. S., Shores, J. T., & Smith, T. A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02395-0 · Cited by 37
Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier
Shimizu, F., Omoto, M., Sano, Y., Mastui, N., Miyashiro, A., Tasaki, A., Maeda, T., Koga, M., Kaji, R., & Kanda, T. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305405 · Cited by 35
Mendoza, S. D., El-Shamayleh, Y., & Horwitz, G. D. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00780.2016 · Cited by 38
Skovbjerg, G., Roostalu, U., Salinas, C. G., Skytte, J. L., Perens, J., Clemmensen, C., Elster, L., Frich, C. K., Hansen, H. H., & Hecksher‐Sørensen, J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109637 · Cited by 31
Kanodia, J., Gadkar, K. G., Bumbaca, D., Zhang, Y., Tong, R., Luk, W., Hoyte, K., Lu, Y., Wildsmith, K., Couch, J., et al. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12081 · Cited by 34
Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions
Kanu, L. N., & Ciolino, J. B. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1890793 · Cited by 34
Mirian, A., Moszczynski, A. J., Soleimani, S., Aubert, I., Zinman, L. H., & Abrahão, A. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.851563 · Cited by 31
A TfR-Binding Cystine-Dense Peptide Promotes Blood–Brain Barrier Penetration of Bioactive Molecules
Crook, Z. R., Girard, E. J., Sevilla, G. P., Merrill, M., Friend, D. J., Rupert, P. B., Pakiam, F. J., Nguyen, E., Yin, C., Ruff, R. O., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.04.002 · Cited by 32
Olthof, M. G. L., Kempen, D. H. R., Herrick, J. L., Yaszemski, M. J., Dhert, W. J. A., & Lu, L. (2017) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33866 · Cited by 31
Effects of transferrin receptor antibody—NGF conjugate on young and aged septal transplants in oculo
Bäckman, C. M., Biddle, P. T., Ebendal, T., Friden, P. M., Gerhardt, G. A., Henry, M. A., Mackerlova, L., Söderström, S., Strömberg, I., Walus, L. R., et al. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90037-3 · Cited by 32
Wuensche, T. E., Stergiou, N., Mes, I., Verlaan, M., Schreurs, M., Kooijman, E. J. M., Janssen, B., Windhorst, A. D., Jensen, A. D., Asuni, A. A., et al. (2022) · Theranostics · doi:10.7150/thno.73509 · Cited by 33
Zafir‐Lavie, I., Sherbo, S., Goltsman, H., Badinter, F., Yeini, E., Ofek, P., Miari, R., Tal, O., Liran, A., Shatil, T., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.017 · Cited by 31
Poduslo, J. F., & Curran, G. L. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00011 · Cited by 31
Self-citationRué, L., Jaspers, T., Degors, I. M. S., Noppen, S., Schols, D., Strooper, B. D., & Dewilde, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061748 · Cited by 32
Ribeiro, M. M. B., Castanho, M. A. R. B., & Serrano, I. D. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791185082 · Cited by 33
Parry, J. A., Olthof, M. G. L., Shogren, K. L., Dadsetan, M., van Wijnen, A. J., Yaszemski, M. J., & Kakar, S. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0343 · Cited by 29
Autoantibodies in Neuropsychiatric Disorders
Hoffmann, C., Zong, S., Mané-Damas, M., Molenaar, P. C., Losen, M. H., & Martínez‐Martínez, P. (2016) · Antibodies · doi:10.3390/antib5020009 · Cited by 30
Neugebauer, K., Hammans, C., Wensing, T., Kumar, V., Grodd, W., Mevissen, L., Sternkopf, M. A., Novakovic, A. M., Abel, T. G., Habel, U., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00275 · Cited by 30
Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies
Stubbs, E. B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113385 · Cited by 30
Georgieva, J. V., Goulatis, L. I., Stutz, C. C., Canfield, S. G., Song, H. W., Gastfriend, B. D., & Shusta, E. V. (2020) · The FASEB Journal · doi:10.1096/fj.202000851r · Cited by 30
Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat
Ruggeri, P., Brunori, A., Cogo, C. E., Storace, D., Nardo, F. D., & Burattini, R. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00644.2005 · Cited by 28
Lu, N.-H., How, S.-C., Lin, C., Tsai, S., Bednáriková, Z., Fedunová, D., Gažová, Z., Wu, J. W., & Wang, S. S. ‐. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.029 · Cited by 28
Central nervous system distribution of fibroblast growth factor injected into the blood stream
Cuevas, P., Fernández-Ayerdi, A., Carceller, F., Colin, S., Mascarelli, F., Muñoz-Willeryt, I., & Giménez‐Gallego, G. (1996) · Neurological Research · doi:10.1080/01616412.1996.11740418 · Cited by 28
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies
Preddy, I., Nandoliya, K. R., Miska, J. M., & Ahmed, A. U. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.012 · Cited by 27
Yosef, N., & Ubogu, E. E. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.01.005 · Cited by 27
Jensen, V. F. H., Mølck, A. ‐., Bøgh, I. B., & Lykkesfeldt, J. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12170 · Cited by 28
Mahoney, M. J., Krewson, C. E., Miller, J. J., & Saltzman, W. M. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1915 · Cited by 27
Potential importance of B cells in aging and aging-associated neurodegenerative diseases
Biragyn, A., Aliseychik, M., & Rogaev, E. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-016-0615-8 · Cited by 25
Brain metastasis models: What should we aim to achieve better treatments?
Masmudi‐Martín, M., Zhu, L., Sánchez‐Navarro, M., Priego, N., Casanova-Acebes, M., Ruiz‐Rodado, V., Giralt, E., & Valiente, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.002 · Cited by 27
Possible Role of Nerve Growth Factor in the Pathogenesis of Alcohol Dependence
Yoon, S. J., Roh, S., Lee, H., Lee, J. W., Lee, B., Kim, Y., & Kim, D. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00120.x · Cited by 26
Tissue engineering of cartilages using biomatrices
Melrose, J., Chuang, C. Y., & Whitelock, J. M. (2008) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.1857 · Cited by 26
Reddy, C. L., Yosef, N., & Ubogu, E. E. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9946-3 · Cited by 26
Sandberg, A., Berenjeno‐Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01141-1 · Cited by 29
Langert, K. A., Zee, C. L. V., & Stubbs, E. B. (2013) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12032 · Cited by 25
Metadata
- Authors
- Poduslo, J. F., Curran, G. L., & Berg, C. T.
- Affiliations
- Mayo Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5705-5709
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC44065
- OpenAlex
- W2071079524
- Cited by
- 377
- References
- 82
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 16 · 2020: 32 · 2019: 16 · 2018: 20 · 2017: 16 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 19
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- blood-nerve barrier, blood-brain barrier, macromolecule permeability, protein permeability, insulin, nerve growth factor, transferrin, IgG, albumin, permeability coefficient, brain regions, brainstem, ventricular fluid, radioiodinated proteins, rats
- MeSH terms
- Albumins, Animals, Blood-Brain Barrier, Brain, Endocytosis, Insulin, Male, Metabolic Clearance Rate, Nerve Growth Factors, Permeability, Transferrin, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review